Literature DB >> 17599917

Cryoelectron tomographic analysis of an HIV-neutralizing protein and its complex with native viral gp120.

Adam Bennett1, Jun Liu, Donald Van Ryk, Donald Bliss, James Arthos, Robert M Henderson, Sriram Subramaniam.   

Abstract

Identifying structural determinants of human immunodeficiency virus (HIV) neutralization is an important component of rational drug and vaccine design. We used cryoelectron tomography and atomic force microscopy to characterize the structure of an extremely potent HIV-neutralizing protein, D1D2-Ig alpha tp (abbreviated as D1D2-IgP), a polyvalent antibody construct that presents dodecameric CD4 in place of the Fab regions. We show that D1D2-IgP has a novel structure, displaying greater flexibility of its antibody arms than the closely related IgM. Using simian immunodeficiency virus in complex with D1D2-IgP, we present unequivocal evidence that D1D2-IgP can cross-link surface spikes on the same virus and on neighboring viruses. The observed binding to the viral envelope spikes is the result of specific CD4-gp120 interaction, because binding was not observed with MICA-IgP, a construct that is identical to D1D2-IgP except that major histocompatibility complex Class I-related Chain A (MICA) replaces the CD4 moiety. CD4-mediated binding was also associated with a significantly elevated proportion of ruptured viruses. The ratio of inactivated to CD4-liganded gp120-gp41 spikes can be much greater than 1:1, because all gp120-gp41 spikes on the closely apposed surfaces of cross-linked viruses should be incapable of accessing the target cell surface and mediating entry, as a result of inter-virus spike cross-linking. These results implicate flexibility rather than steric bulk or polyvalence per se as a structural explanation for the extreme potency of D1D2-IgP and thus suggest polyvalence presented on a flexible scaffold as a key design criterion for small molecule HIV entry inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599917     DOI: 10.1074/jbc.M702025200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Electron tomography of viruses.

Authors:  Sriram Subramaniam; Alberto Bartesaghi; Jun Liu; Adam E Bennett; Rachid Sougrat
Journal:  Curr Opin Struct Biol       Date:  2007-10-25       Impact factor: 6.809

2.  Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion.

Authors:  Sundaram A Vishwanathan; Eric Hunter
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

3.  Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains.

Authors:  Weizao Chen; Yang Feng; Ponraj Prabakaran; Tianlei Ying; Yanping Wang; Jianping Sun; Camila D S Macedo; Zhongyu Zhu; Yuxian He; Victoria R Polonis; Dimiter S Dimitrov
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

4.  Structural evolution of glycan recognition by a family of potent HIV antibodies.

Authors:  Fernando Garces; Devin Sok; Leopold Kong; Ryan McBride; Helen J Kim; Karen F Saye-Francisco; Jean-Philippe Julien; Yuanzi Hua; Albert Cupo; John P Moore; James C Paulson; Andrew B Ward; Dennis R Burton; Ian A Wilson
Journal:  Cell       Date:  2014-09-25       Impact factor: 41.582

5.  Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer.

Authors:  Li Liu; Raffaello Cimbro; Paolo Lusso; Edward A Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-29       Impact factor: 11.205

6.  Cell-free HIV-1 virucidal action by modified peptide triazole inhibitors of Env gp120.

Authors:  Arangassery R Bastian; Karyn McFadden; Caitlin Duffy; Srivats Rajagopal; Mark R Contarino; Elisabeth Papazoglou; Irwin Chaiken
Journal:  ChemMedChem       Date:  2011-06-28       Impact factor: 3.466

7.  Molecular architecture of native HIV-1 gp120 trimers.

Authors:  Jun Liu; Alberto Bartesaghi; Mario J Borgnia; Guillermo Sapiro; Sriram Subramaniam
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

8.  Few and far between: how HIV may be evading antibody avidity.

Authors:  Joshua S Klein; Pamela J Bjorkman
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

9.  Estimating the stoichiometry of HIV neutralization.

Authors:  Carsten Magnus; Roland R Regoes
Journal:  PLoS Comput Biol       Date:  2010-03-19       Impact factor: 4.475

10.  Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization.

Authors:  Emma T Crooks; Pengfei Jiang; Michael Franti; Sharon Wong; Michael B Zwick; James A Hoxie; James E Robinson; Penny L Moore; James M Binley
Journal:  Virology       Date:  2008-06-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.